Catheter-based adenovirus-mediated local intravascular gene delivery of a soluble TGF-beta type II receptor using an infiltrator in porcine coronary arteries: efficacy and complications
Enhanced extracellular matrix (ECM) accumulation is an important finding in human restenotic arterial neointima after angioplasty. Transforming growth factor beta1(TGF-beta1) is known to regulate the synthesis and turnover of a variety of ECM components, and may play an important role in restenosis....
Gespeichert in:
| Veröffentlicht in: | Experimental & molecular medicine 2002-09, Vol.34 (4), p.299-307 |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 307 |
|---|---|
| container_issue | 4 |
| container_start_page | 299 |
| container_title | Experimental & molecular medicine |
| container_volume | 34 |
| creator | Chung, Ick-Mo Ueno, Hikaru Pak, Youngmi Kim Kim, Joon-Woo Choi, Dong-Hoon Shin, Gil Ja Yang, Woo-Ick Jang, Yang soo |
| description | Enhanced extracellular matrix (ECM) accumulation is an important finding in human restenotic arterial neointima after angioplasty. Transforming growth factor beta1(TGF-beta1) is known to regulate the synthesis and turnover of a variety of ECM components, and may play an important role in restenosis. Recombinant adenoviral vector expressing an ectodomain of the TGF-beta type II receptor fused to the human immunoglobulin Fc portion (AdTbeta-ExR) inhibits the action of TGF-beta probably either by adsorbing TGF-beta or by acting as a dominant negative receptor. We carried out a catheter-based local adenovirus mediated gene delivery using an Infiltrator in porcine coronary arteries to know the pattern of gene expression, efficacy and procedural complications. Twenty four coronary arteries in 13 pigs were used for intravascular gene delivery by intramural injection with either AdTbeta-ExR or adenovirus expressing beta-galactosidase (AdCALacZ). Direct immunofluorescent staining and reverse transcription polymerase chain reaction (RT-PCR) were used for detection of type II TGF-beta receptor and its mRNA respectively. X-Gal histochemistry was performed to identify beta-galactosidase. Both soluble TGF-beta receptor and beta-galactosidase were expressed locally in the media and adventita at injected arterial segments without any significant dissemination to remote area. Intravascular gene transfection performed with various titer of each adenoviral vector showed that AdTbeta-ExR of 5 x 10(8) pfu and AdCALacZ of 2.5 x 10(8) pfu were the minimum titer for the expression of each transgene. Infiltration of CD3 positive T cells was detected by immunohistochemical staining in the area of each transgene expression, and tends to decrease over time after gene delivery. Pathological study of 24 treated arteries showed complications such as disruption of external elastic lamina with hemorrhage (n = 4), minimal disruption of internal elastic lamina and endothelial layer, and medial thickening. In conclusion, catheter-based local intravascular gene delivery of adenoviral vector is feasible and effective in a selected artery, but must be undertaken with caution due to possible lethal complications. Local delivery of soluble TGF-beta type II receptor in this way may provide an effective intravascular gene therapy to inhibit TGF-beta signal pathway without any significant systemic side effect. |
| doi_str_mv | 10.1038/emm.2002.42 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72806622</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1846397817</sourcerecordid><originalsourceid>FETCH-LOGICAL-c355t-b9c58a03e41c02ad987b2da9b0391214854d66507fe00f1babb106a78e2f392d3</originalsourceid><addsrcrecordid>eNp9kU2LFDEQhoMo7rh68i45iSA95qvT3d5kcNeBBS_ruamkq9dIOmmT9MD-NP-dGXbAm6cibx4eqngJecvZnjPZf8Jl2QvGxF6JZ2Qn2CAarbh8TnZcCN1IzeUVeZXzr8q0qlMvyRUXLW_loHfkzwHKTyyYGgMZJwoThnhyacvNgpODUjMfLXjqQklwgmw3D4k-YEA6oXcnTI80zhRojn4zHun97U1jsAAtjyvS45EmtLiWmOiWXXigEKprdr7qzqELdI3JuuqzMcUA1QepbuQwf6Y4z86CrVGY6v-y-vosLob8mryYwWd8c5nX5MfN1_vDt-bu--3x8OWusbJtS2MG2_bAJCpumYBp6DsjJhgMkwMXXPWtmrRuWTcjYzM3YAxnGroexSwHMclr8v7Ju6b4e8NcxsVli95DwLjlsRM901qICn74L8h7peXQ9byr6Mcn1KaYc8J5XJNb6uUjZ-O51LGWOp5LHdVZ_O4i3kwt5R97aVH-BTrAoQU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1846397817</pqid></control><display><type>article</type><title>Catheter-based adenovirus-mediated local intravascular gene delivery of a soluble TGF-beta type II receptor using an infiltrator in porcine coronary arteries: efficacy and complications</title><source>MEDLINE</source><source>Springer Nature OA Free Journals</source><source>Nature Free</source><source>KoreaMed Open Access</source><source>DOAJ Directory of Open Access Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Free Full-Text Journals in Chemistry</source><creator>Chung, Ick-Mo ; Ueno, Hikaru ; Pak, Youngmi Kim ; Kim, Joon-Woo ; Choi, Dong-Hoon ; Shin, Gil Ja ; Yang, Woo-Ick ; Jang, Yang soo</creator><creatorcontrib>Chung, Ick-Mo ; Ueno, Hikaru ; Pak, Youngmi Kim ; Kim, Joon-Woo ; Choi, Dong-Hoon ; Shin, Gil Ja ; Yang, Woo-Ick ; Jang, Yang soo</creatorcontrib><description>Enhanced extracellular matrix (ECM) accumulation is an important finding in human restenotic arterial neointima after angioplasty. Transforming growth factor beta1(TGF-beta1) is known to regulate the synthesis and turnover of a variety of ECM components, and may play an important role in restenosis. Recombinant adenoviral vector expressing an ectodomain of the TGF-beta type II receptor fused to the human immunoglobulin Fc portion (AdTbeta-ExR) inhibits the action of TGF-beta probably either by adsorbing TGF-beta or by acting as a dominant negative receptor. We carried out a catheter-based local adenovirus mediated gene delivery using an Infiltrator in porcine coronary arteries to know the pattern of gene expression, efficacy and procedural complications. Twenty four coronary arteries in 13 pigs were used for intravascular gene delivery by intramural injection with either AdTbeta-ExR or adenovirus expressing beta-galactosidase (AdCALacZ). Direct immunofluorescent staining and reverse transcription polymerase chain reaction (RT-PCR) were used for detection of type II TGF-beta receptor and its mRNA respectively. X-Gal histochemistry was performed to identify beta-galactosidase. Both soluble TGF-beta receptor and beta-galactosidase were expressed locally in the media and adventita at injected arterial segments without any significant dissemination to remote area. Intravascular gene transfection performed with various titer of each adenoviral vector showed that AdTbeta-ExR of 5 x 10(8) pfu and AdCALacZ of 2.5 x 10(8) pfu were the minimum titer for the expression of each transgene. Infiltration of CD3 positive T cells was detected by immunohistochemical staining in the area of each transgene expression, and tends to decrease over time after gene delivery. Pathological study of 24 treated arteries showed complications such as disruption of external elastic lamina with hemorrhage (n = 4), minimal disruption of internal elastic lamina and endothelial layer, and medial thickening. In conclusion, catheter-based local intravascular gene delivery of adenoviral vector is feasible and effective in a selected artery, but must be undertaken with caution due to possible lethal complications. Local delivery of soluble TGF-beta type II receptor in this way may provide an effective intravascular gene therapy to inhibit TGF-beta signal pathway without any significant systemic side effect.</description><identifier>ISSN: 1226-3613</identifier><identifier>ISSN: 2092-6413</identifier><identifier>EISSN: 2092-6413</identifier><identifier>DOI: 10.1038/emm.2002.42</identifier><identifier>PMID: 12515396</identifier><language>eng</language><publisher>United States</publisher><subject>Adenoviridae ; Adenoviridae - genetics ; Animals ; beta-Galactosidase - genetics ; beta-Galactosidase - metabolism ; Catheters, Indwelling ; Coronary Vessels - metabolism ; Coronary Vessels - pathology ; Female ; Gene Expression ; Gene Transfer Techniques ; Genetic Therapy - adverse effects ; Genetic Therapy - methods ; Genetic Therapy - mortality ; Genetic Vectors - administration & dosage ; Inflammation - etiology ; Receptors, Transforming Growth Factor beta - analysis ; Receptors, Transforming Growth Factor beta - metabolism ; Swine ; Transgenes</subject><ispartof>Experimental & molecular medicine, 2002-09, Vol.34 (4), p.299-307</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c355t-b9c58a03e41c02ad987b2da9b0391214854d66507fe00f1babb106a78e2f392d3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,860,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12515396$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chung, Ick-Mo</creatorcontrib><creatorcontrib>Ueno, Hikaru</creatorcontrib><creatorcontrib>Pak, Youngmi Kim</creatorcontrib><creatorcontrib>Kim, Joon-Woo</creatorcontrib><creatorcontrib>Choi, Dong-Hoon</creatorcontrib><creatorcontrib>Shin, Gil Ja</creatorcontrib><creatorcontrib>Yang, Woo-Ick</creatorcontrib><creatorcontrib>Jang, Yang soo</creatorcontrib><title>Catheter-based adenovirus-mediated local intravascular gene delivery of a soluble TGF-beta type II receptor using an infiltrator in porcine coronary arteries: efficacy and complications</title><title>Experimental & molecular medicine</title><addtitle>Exp Mol Med</addtitle><description>Enhanced extracellular matrix (ECM) accumulation is an important finding in human restenotic arterial neointima after angioplasty. Transforming growth factor beta1(TGF-beta1) is known to regulate the synthesis and turnover of a variety of ECM components, and may play an important role in restenosis. Recombinant adenoviral vector expressing an ectodomain of the TGF-beta type II receptor fused to the human immunoglobulin Fc portion (AdTbeta-ExR) inhibits the action of TGF-beta probably either by adsorbing TGF-beta or by acting as a dominant negative receptor. We carried out a catheter-based local adenovirus mediated gene delivery using an Infiltrator in porcine coronary arteries to know the pattern of gene expression, efficacy and procedural complications. Twenty four coronary arteries in 13 pigs were used for intravascular gene delivery by intramural injection with either AdTbeta-ExR or adenovirus expressing beta-galactosidase (AdCALacZ). Direct immunofluorescent staining and reverse transcription polymerase chain reaction (RT-PCR) were used for detection of type II TGF-beta receptor and its mRNA respectively. X-Gal histochemistry was performed to identify beta-galactosidase. Both soluble TGF-beta receptor and beta-galactosidase were expressed locally in the media and adventita at injected arterial segments without any significant dissemination to remote area. Intravascular gene transfection performed with various titer of each adenoviral vector showed that AdTbeta-ExR of 5 x 10(8) pfu and AdCALacZ of 2.5 x 10(8) pfu were the minimum titer for the expression of each transgene. Infiltration of CD3 positive T cells was detected by immunohistochemical staining in the area of each transgene expression, and tends to decrease over time after gene delivery. Pathological study of 24 treated arteries showed complications such as disruption of external elastic lamina with hemorrhage (n = 4), minimal disruption of internal elastic lamina and endothelial layer, and medial thickening. In conclusion, catheter-based local intravascular gene delivery of adenoviral vector is feasible and effective in a selected artery, but must be undertaken with caution due to possible lethal complications. Local delivery of soluble TGF-beta type II receptor in this way may provide an effective intravascular gene therapy to inhibit TGF-beta signal pathway without any significant systemic side effect.</description><subject>Adenoviridae</subject><subject>Adenoviridae - genetics</subject><subject>Animals</subject><subject>beta-Galactosidase - genetics</subject><subject>beta-Galactosidase - metabolism</subject><subject>Catheters, Indwelling</subject><subject>Coronary Vessels - metabolism</subject><subject>Coronary Vessels - pathology</subject><subject>Female</subject><subject>Gene Expression</subject><subject>Gene Transfer Techniques</subject><subject>Genetic Therapy - adverse effects</subject><subject>Genetic Therapy - methods</subject><subject>Genetic Therapy - mortality</subject><subject>Genetic Vectors - administration & dosage</subject><subject>Inflammation - etiology</subject><subject>Receptors, Transforming Growth Factor beta - analysis</subject><subject>Receptors, Transforming Growth Factor beta - metabolism</subject><subject>Swine</subject><subject>Transgenes</subject><issn>1226-3613</issn><issn>2092-6413</issn><issn>2092-6413</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kU2LFDEQhoMo7rh68i45iSA95qvT3d5kcNeBBS_ruamkq9dIOmmT9MD-NP-dGXbAm6cibx4eqngJecvZnjPZf8Jl2QvGxF6JZ2Qn2CAarbh8TnZcCN1IzeUVeZXzr8q0qlMvyRUXLW_loHfkzwHKTyyYGgMZJwoThnhyacvNgpODUjMfLXjqQklwgmw3D4k-YEA6oXcnTI80zhRojn4zHun97U1jsAAtjyvS45EmtLiWmOiWXXigEKprdr7qzqELdI3JuuqzMcUA1QepbuQwf6Y4z86CrVGY6v-y-vosLob8mryYwWd8c5nX5MfN1_vDt-bu--3x8OWusbJtS2MG2_bAJCpumYBp6DsjJhgMkwMXXPWtmrRuWTcjYzM3YAxnGroexSwHMclr8v7Ju6b4e8NcxsVli95DwLjlsRM901qICn74L8h7peXQ9byr6Mcn1KaYc8J5XJNb6uUjZ-O51LGWOp5LHdVZ_O4i3kwt5R97aVH-BTrAoQU</recordid><startdate>20020930</startdate><enddate>20020930</enddate><creator>Chung, Ick-Mo</creator><creator>Ueno, Hikaru</creator><creator>Pak, Youngmi Kim</creator><creator>Kim, Joon-Woo</creator><creator>Choi, Dong-Hoon</creator><creator>Shin, Gil Ja</creator><creator>Yang, Woo-Ick</creator><creator>Jang, Yang soo</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>7T5</scope><scope>7U9</scope><scope>8FD</scope><scope>FR3</scope><scope>H94</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope></search><sort><creationdate>20020930</creationdate><title>Catheter-based adenovirus-mediated local intravascular gene delivery of a soluble TGF-beta type II receptor using an infiltrator in porcine coronary arteries: efficacy and complications</title><author>Chung, Ick-Mo ; Ueno, Hikaru ; Pak, Youngmi Kim ; Kim, Joon-Woo ; Choi, Dong-Hoon ; Shin, Gil Ja ; Yang, Woo-Ick ; Jang, Yang soo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c355t-b9c58a03e41c02ad987b2da9b0391214854d66507fe00f1babb106a78e2f392d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Adenoviridae</topic><topic>Adenoviridae - genetics</topic><topic>Animals</topic><topic>beta-Galactosidase - genetics</topic><topic>beta-Galactosidase - metabolism</topic><topic>Catheters, Indwelling</topic><topic>Coronary Vessels - metabolism</topic><topic>Coronary Vessels - pathology</topic><topic>Female</topic><topic>Gene Expression</topic><topic>Gene Transfer Techniques</topic><topic>Genetic Therapy - adverse effects</topic><topic>Genetic Therapy - methods</topic><topic>Genetic Therapy - mortality</topic><topic>Genetic Vectors - administration & dosage</topic><topic>Inflammation - etiology</topic><topic>Receptors, Transforming Growth Factor beta - analysis</topic><topic>Receptors, Transforming Growth Factor beta - metabolism</topic><topic>Swine</topic><topic>Transgenes</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chung, Ick-Mo</creatorcontrib><creatorcontrib>Ueno, Hikaru</creatorcontrib><creatorcontrib>Pak, Youngmi Kim</creatorcontrib><creatorcontrib>Kim, Joon-Woo</creatorcontrib><creatorcontrib>Choi, Dong-Hoon</creatorcontrib><creatorcontrib>Shin, Gil Ja</creatorcontrib><creatorcontrib>Yang, Woo-Ick</creatorcontrib><creatorcontrib>Jang, Yang soo</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Experimental & molecular medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chung, Ick-Mo</au><au>Ueno, Hikaru</au><au>Pak, Youngmi Kim</au><au>Kim, Joon-Woo</au><au>Choi, Dong-Hoon</au><au>Shin, Gil Ja</au><au>Yang, Woo-Ick</au><au>Jang, Yang soo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Catheter-based adenovirus-mediated local intravascular gene delivery of a soluble TGF-beta type II receptor using an infiltrator in porcine coronary arteries: efficacy and complications</atitle><jtitle>Experimental & molecular medicine</jtitle><addtitle>Exp Mol Med</addtitle><date>2002-09-30</date><risdate>2002</risdate><volume>34</volume><issue>4</issue><spage>299</spage><epage>307</epage><pages>299-307</pages><issn>1226-3613</issn><issn>2092-6413</issn><eissn>2092-6413</eissn><abstract>Enhanced extracellular matrix (ECM) accumulation is an important finding in human restenotic arterial neointima after angioplasty. Transforming growth factor beta1(TGF-beta1) is known to regulate the synthesis and turnover of a variety of ECM components, and may play an important role in restenosis. Recombinant adenoviral vector expressing an ectodomain of the TGF-beta type II receptor fused to the human immunoglobulin Fc portion (AdTbeta-ExR) inhibits the action of TGF-beta probably either by adsorbing TGF-beta or by acting as a dominant negative receptor. We carried out a catheter-based local adenovirus mediated gene delivery using an Infiltrator in porcine coronary arteries to know the pattern of gene expression, efficacy and procedural complications. Twenty four coronary arteries in 13 pigs were used for intravascular gene delivery by intramural injection with either AdTbeta-ExR or adenovirus expressing beta-galactosidase (AdCALacZ). Direct immunofluorescent staining and reverse transcription polymerase chain reaction (RT-PCR) were used for detection of type II TGF-beta receptor and its mRNA respectively. X-Gal histochemistry was performed to identify beta-galactosidase. Both soluble TGF-beta receptor and beta-galactosidase were expressed locally in the media and adventita at injected arterial segments without any significant dissemination to remote area. Intravascular gene transfection performed with various titer of each adenoviral vector showed that AdTbeta-ExR of 5 x 10(8) pfu and AdCALacZ of 2.5 x 10(8) pfu were the minimum titer for the expression of each transgene. Infiltration of CD3 positive T cells was detected by immunohistochemical staining in the area of each transgene expression, and tends to decrease over time after gene delivery. Pathological study of 24 treated arteries showed complications such as disruption of external elastic lamina with hemorrhage (n = 4), minimal disruption of internal elastic lamina and endothelial layer, and medial thickening. In conclusion, catheter-based local intravascular gene delivery of adenoviral vector is feasible and effective in a selected artery, but must be undertaken with caution due to possible lethal complications. Local delivery of soluble TGF-beta type II receptor in this way may provide an effective intravascular gene therapy to inhibit TGF-beta signal pathway without any significant systemic side effect.</abstract><cop>United States</cop><pmid>12515396</pmid><doi>10.1038/emm.2002.42</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1226-3613 |
| ispartof | Experimental & molecular medicine, 2002-09, Vol.34 (4), p.299-307 |
| issn | 1226-3613 2092-6413 2092-6413 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_72806622 |
| source | MEDLINE; Springer Nature OA Free Journals; Nature Free; KoreaMed Open Access; DOAJ Directory of Open Access Journals; EZB-FREE-00999 freely available EZB journals; Free Full-Text Journals in Chemistry |
| subjects | Adenoviridae Adenoviridae - genetics Animals beta-Galactosidase - genetics beta-Galactosidase - metabolism Catheters, Indwelling Coronary Vessels - metabolism Coronary Vessels - pathology Female Gene Expression Gene Transfer Techniques Genetic Therapy - adverse effects Genetic Therapy - methods Genetic Therapy - mortality Genetic Vectors - administration & dosage Inflammation - etiology Receptors, Transforming Growth Factor beta - analysis Receptors, Transforming Growth Factor beta - metabolism Swine Transgenes |
| title | Catheter-based adenovirus-mediated local intravascular gene delivery of a soluble TGF-beta type II receptor using an infiltrator in porcine coronary arteries: efficacy and complications |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T08%3A04%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Catheter-based%20adenovirus-mediated%20local%20intravascular%20gene%20delivery%20of%20a%20soluble%20TGF-beta%20type%20II%20receptor%20using%20an%20infiltrator%20in%20porcine%20coronary%20arteries:%20efficacy%20and%20complications&rft.jtitle=Experimental%20&%20molecular%20medicine&rft.au=Chung,%20Ick-Mo&rft.date=2002-09-30&rft.volume=34&rft.issue=4&rft.spage=299&rft.epage=307&rft.pages=299-307&rft.issn=1226-3613&rft.eissn=2092-6413&rft_id=info:doi/10.1038/emm.2002.42&rft_dat=%3Cproquest_cross%3E1846397817%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1846397817&rft_id=info:pmid/12515396&rfr_iscdi=true |